These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11575041)

  • 21. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application.
    Blake GJ; Ridker PM
    Ital Heart J; 2001 Nov; 2(11):796-800. PubMed ID: 11770860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment.
    Insull W
    Am J Med; 2009 Jan; 122(1 Suppl):S3-S14. PubMed ID: 19110086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What do the statins tell us?
    LaRosa JC
    Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-density lipoprotein reduction by simvastatin is accompanied by angiotensin II type 1 receptor downregulation, reduced oxidative stress, and improved endothelial function in patients with stable coronary artery disease.
    Kiliszek M; Maczewski M; Styczyński G; Duda M; Opolski G; Beresewicz A
    Coron Artery Dis; 2007 May; 18(3):201-9. PubMed ID: 17429294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
    Wierzbicki AS
    Curr Med Res Opin; 2005 Feb; 21(2):299-306. PubMed ID: 15802001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular function and mild renal impairment in stable coronary artery disease.
    van der Harst P; Smilde TD; Buikema H; Voors AA; Navis G; van Veldhuisen DJ; van Gilst WH
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):379-84. PubMed ID: 16306429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress.
    Takahashi S; Papafaklis MI; Sakamoto S; Antoniadis AP; Coskun AU; Feldman CL; Stone PH
    Curr Opin Lipidol; 2011 Oct; 22(5):358-64. PubMed ID: 21841484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of benefit of angiotensin receptor blockers in coronary atherosclerosis.
    Vaccari CS; Lerakis S; Hammoud R; Khan BV
    Am J Med Sci; 2008 Sep; 336(3):270-7. PubMed ID: 18794623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regression of coronary artery disease: the role of plaque biology.
    Valle BK; Valle GA; Lemberg L
    Am J Crit Care; 1995 Nov; 4(6):481-4. PubMed ID: 8556091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.
    Jasińska M; Owczarek J; Orszulak-Michalak D
    Pharmacol Rep; 2007; 59(5):483-99. PubMed ID: 18048949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the coronary disease process and the potential for prevention: a summary.
    Fuster V
    Prev Med; 1999 Dec; 29(6 Pt 2):S9-10. PubMed ID: 10641811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unstable atherosclerotic plaque. Pathophysiology and therapeutic guidelines.
    Berkenboom G
    Acta Cardiol; 1998; 53(4):235-41. PubMed ID: 9842411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress.
    Andreou I; Antoniadis AP; Shishido K; Papafaklis MI; Koskinas KC; Chatzizisis YS; Coskun AU; Edelman ER; Feldman CL; Stone PH
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):261-75. PubMed ID: 25336461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why vascular biology matters.
    Pepine CJ
    Am J Cardiol; 2001 Oct; 88(8A):5K-9K. PubMed ID: 11694212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease.
    Selwyn AP; Kinlay S; Creager M; Libby P; Ganz P
    Am J Cardiol; 1997 Mar; 79(5A):17-23. PubMed ID: 9127617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial dysfunction in coronary heart disease.
    McGorisk GM; Treasure CB
    Curr Opin Cardiol; 1996 Jul; 11(4):341-50. PubMed ID: 8879944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.